Treatment outcomes of adult patients with recurrent tuberculosis in relation to HIV status in Zimbabwe: A retrospective record review

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Takarinda, Kudakwashe C ^a   Harries, Anthony D ^b,c   Srinath, Satyanarayana ^b   Mutasa Apollo, Tsitsi ^a   Sandy, Charles ^a   Mugurungi, Owen ^a  

^a MINISTRY OF HEALTH AND CHILD CARE   (Zimbabwe)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HIV; Recurrent tuberculosis; Treatment outcomes; Zimbabwe

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MEDICAL AUDIT; MIDDLE AGED; MIXED INFECTION; OUTCOME ASSESSMENT; RECURRENT DISEASE; RETROSPECTIVE STUDY; TUBERCULOSIS; ZIMBABWE;

ADULT; ANTITUBERCULAR AGENTS; COINFECTION; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RECURRENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT; ZIMBABWE;

EID: 84856787466     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-124     Document Type: Review

References (21)

1. World Health Organisation, Global tuberculosis control: WHO Report 2010 Geneva 2010
2. Harries AD Maher D, TB/HIV A clinical manual Geneva: World Health Organisation 1996
3. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Corbett EL Watt CJ Walker N Maher D, William BG Raviglione MC, Dye C,, Arch Intern Med 2003 163 Suppl 9 1009 1021 12742798 (Pubitemid 36548927)
4. Tuberculosis Trials Consortium: Recurrent Tuberculosis in the United States and Canada: relapse or reinfection? Jasmer R Bozeman L, Schwartzman K Cave MD, Saukkonen JJ Metchock B, Khan A Burman WJ, Am J Respir Crit Care Med 2004 170 Suppl 12 1360 1366 15477492 (Pubitemid 39657201)
5. Recurrent TB: relapse or reinfecion? The effect of HIV in a general population cohort in Malawi. Crampin AC Mwaungulu JN, Mwaungulu FD Mwafulirwa DT, Munthali K Floyd S, Fine PE Glynn JR, AIDS 2010 24 Suppl 3 417 426 20042847
6. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Sonnenberg P Murray J, Glynn JR Shearer S, Kambashi B Godfrey-Faussett P, Lancet 2001 358 1687 1693 10.1016/S0140-6736(01)06712-5 11728545 (Pubitemid 33124328)
7. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia. Elliott AM Halwiindi B Hayes RJ Luo N, Mwinga AG Tembo G, Machiels L Steenbergen G, Pobee JOM Nunn P, McAdam KPW,, J Trop Med Hyg 1995 98 9 21 7861484
8. An investigation of suspected exogeneous reinfection in tuberculosis patients in Kampala, Uganda. Fitzpatrick LK Okwera A, Mugerwa R Ridzon R, Ehiner J Onorato I, Int J Tuberc Lung Dis 2002 6 Suppl 6 550 552 12068990 (Pubitemid 34601874)
9. Impact of HIV infection on the recurrence of tuberculosis in South India. Narayanan S Swaminathan S, Supply P Shanmugam S, Narendran G Hari L, Ramachandran R Locht C, Jawahar MS Narayanan PR, J Infect Dis 2010 201 Suppl 5 691 703 20121433
10. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampicin-based treatment: An analytical Review. Korenromp EL Scano F Williams BG Dye C, Nunn P,, Clin Infect Dis 2003 37 Suppl 1 101 112 12830415 (Pubitemid 36836652)
11. Timing of ART initiation during TB treatment may not have significant impact on risk of death. Odendal L, http://www.aidsmap.com/page/1439095/
12. Voluntary counseling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. Zachariah R Spielmann MP, Chinji C Gomani P, Arendt V Hargreaves NJ, Salaniponi FM Harries AD, AIDS 2003 17 Suppl 7 1053 1061 12700456 (Pubitemid 36549718)
13. Starting ARV therapy at three points in TB therapy. Abdool Karim SS Naidoo K Grobler A Padayatchi N, Baxter C Gray A, Gengiah T Nair G, Bamber S Singh A, Khan M Pienaar J, El-Sadr W Friedland G, Abdool Karim Q,, N Engl J Med 2010 362 697 706 10.1056/NEJMoa0905848 20181971
14. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India. Raizada N Chauhan LS, Babu BS Thakur R, Khera A Wares DF, Suvanand S Bachani D, Rewari BB Dewan PK, PLoS One 2009 4 6 5999 10.1371/journal.pone.0005999 19543396
15. Survival rate and risk factors of mortality among HIV/tuberculosis- coinfected patients with and without antiretroviral therapy. Manosuthi W Chottanapand S Thongyen S Chaovavanich A, Sungkanuparph S,, J Acquir Immune Defic Syndr 2006 43 Suppl 1 42 46 16885778 (Pubitemid 44306486)
16. Chitungwiza informations. City Chitungwiza in Zimbabwe. http://athaia.org/Zimbabwe/chitungwiza.html
17. Ministry of Health and Child Welfare, Zimbabwe National Tuberculosis Control Programme Manual Harare, Zimbabwe: Ministry of Health and Child Welfare 3 2007
18. Ministry of Health and Child Welfare, National HIV Testing and Counselling Training Manual Harare, Zimbabwe: Ministry of Health and Child Welfare 2007
19. Ministry of Health and Child Welfare, National Guidelines for TB/HIV Co-management Harare, Zimbabwe: Ministry of Health and Child Welfare 2009
20. Ministry of Health and Child WelfareNational Drug and Therapeutics Policy Advisory Committee, Guidelines for antiretroviral therapy in Zimbabwe Harare, Zimbabwe: Ministry of Health and Child Welfare 2007
21. A modified poisson regression approach to prospective studies with binary data. Zou G, Am J Epidemiol 2004 159 Suppl 7 702 706 15033648 (Pubitemid 38405384)